Aparna Kesarwala, MD, PhD

Role

Radiation Oncology
Specialty

Lung Cancer
Research Program

Cell and Molecular Biology
Practicing Since

2013

Request Appointment

Background

Aparna H. Kesarwala, MD, PhD, is Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine. A board certified radiation oncologist, Dr. Kesarwala specializes in the treatment of thoracic malignancies, and treats patients at Emory University Hospital Midtown.
Prior to joining Emory, Dr. Kesarwala was Assistant Research Physician at the National Cancer Institute.
Education
Dr. Kesarwala earned her MD and her PhD in Molecular Cell Biology from Washington University School of Medicine. She completed an internship at Yale-New Haven Hospital and a radiation oncology residency at the National Cancer Institute/National Capital Consortium.
Research
Dr. Kesarwala's research interests are at the interface among radiation biology and oncology, cancer cell metabolism, and molecular imaging.
Publications
PubMed

Titles & Roles

Assistant Professor, Department of Radiation Oncology

Emory University School of Medicine

Education & Training

Education

Residency, Radiation Oncology, 2013
National Cancer Institute
Fellowship, Radiation Oncology, 2013
National Cancer Institute
Internship, Internal Medicine, 2009
Yale New Haven Hospital
Medical Education, , 2008
Washington Univ School of Med
Medical Education, , 2008
Washington University in St Louis

Board Certifications

Radiation Oncology
American Board of Radiology, 2015

View Current Clinical Trials


Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer Phase III Conditions Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Location Emory Saint Joseph's Hospital, Emory Proton Therapy Center, Winship Cancer Institute

Title/Journal	Authors	Publication Date
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node. Research square	Y Shen, E Connolly, M Aiello, C Zhou, P Chappa, H Song, P Tippitak, T Clark, M Cardenas, N Prokhnevska, A Mariniello, MS Pagadala, VR Dhere, S Rafiq, AH Kesarwala, A Orthwein, SN Thomas, MK Khan, J Brandon Dixon, GB Lesinski, MC Lowe, H Kissick, DS Yu, CM Paulos, NC Schmitt, ZS Buchwald	06/03/2024
Deformable lung 4DCT image registration via landmark-driven cycle network. Medical physics	L Matkovic, Y Lei, Y Fu, T Wang, AH Kesarwala, M Axente, J Roper, K Higgins, JD Bradley, T Liu, X Yang	01/03/2024
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer. Cancer	NS McCall, JR Janopaul-Naylor, HS McGinnis, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, TA Leal, SS Ramalingam, JD Bradley, KA Higgins	01/12/2023
Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Outcomes from the Proton Collaborative Group Prospective Registry. International journal of radiation oncology, biology, physics	S Tian, A McCook, IJ Choi, CB Simone, CE Vargas, NY Yu, JHC Chang, SA Mihalcik, H Tsai, J Zeng, LR Rosen, ZH Rana, JJ Urbanic, WA Stokes, AH Kesarwala, JD Bradley, KA Higgins	01/10/2023
Deep learning-based fast volumetric imaging using kV and MV projection images for lung cancer radiotherapy: A feasibility study. Medical physics	Y Lei, Z Tian, T Wang, J Roper, H Xie, AH Kesarwala, K Higgins, JD Bradley, T Liu, X Yang	01/09/2023
The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. Blood advances	S Findlay, R Nair, RA Merrill, Z Kaiser, A Cajelot, Z Aryanpour, J Heath, C St-Louis, D Papadopoli, I Topisirovic, J St-Pierre, M Sebag, AH Kesarwala, L Hulea, EB Taylor, M Shanmugam, A Orthwein	25/07/2023
Automated lung tumor delineation on positron emission tomography/computed tomography via a hybrid regional network. Medical physics	Y Lei, T Wang, JJ Jeong, J Janopaul-Naylor, AH Kesarwala, J Roper, S Tian, JD Bradley, T Liu, K Higgins, X Yang	01/01/2023
Compact portable sources of high-LET radiation: Validation and potential application for galactic cosmic radiation countermeasure discovery. Life sciences in space research	NE Hertel, SR Biegalski, VI Nelson, WA Nelson, S Mukhopadhyay, Z Su, AM Chan, AH Kesarwala, WS Dynan	01/11/2022
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	NS McCall, HS McGinnis, JR Janopaul-Naylor, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, T Leal, SS Ramalingam, JD Bradley, KA Higgins	01/09/2022
Metabolic response to radiation therapy in cancer. Molecular carcinogenesis	GH Read, J Bailleul, E Vlashi, AH Kesarwala	01/02/2022
Race, Ethnicity, and Sex Among Senior Faculty in Radiation Oncology From 2000 to 2019. JAMA network open	JR Janopaul-Naylor, SE Roberts, HK Shu, AH Kesarwala, JY Lin, JM Switchenko, MA Torres	04/01/2022
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era. Frontiers in oncology	JR Janopaul-Naylor, Y Cao, NS McCall, JM Switchenko, S Tian, H Chen, WA Stokes, AH Kesarwala, MW McDonald, JW Shelton, JD Bradley, KA Higgins	01/01/2022
Simple Esterification of [1-¹³C]-Alpha-Ketoglutarate Enhances Membrane Permeability and Allows for Noninvasive Tracing of Glutamate and Glutamine Production. ACS chemical biology	JE AbuSalim, K Yamamoto, N Miura, B Blackman, JR Brender, C Mushti, T Seki, KA Camphausen, RE Swenson, MC Krishna, AH Kesarwala	19/11/2021
Lung tumor segmentation in 4D CT images using motion convolutional neural networks. Medical physics	S Momin, Y Lei, Z Tian, T Wang, J Roper, AH Kesarwala, K Higgins, JD Bradley, T Liu, X Yang	01/11/2021
Synthesis of [1-¹³ C-5-¹² C]-alpha-ketoglutarate enables noninvasive detection of 2-hydroxyglutarate. NMR in biomedicine	N Miura, C Mushti, D Sail, JE AbuSalim, K Yamamoto, JR Brender, T Seki, DI AbuSalim, S Matsumoto, KA Camphausen, MC Krishna, RE Swenson, AH Kesarwala	01/11/2021
Deep learning-based thoracic CBCT correction with histogram matching. Biomedical physics & engineering express	RLJ Qiu, Y Lei, J Shelton, K Higgins, JD Bradley, WJ Curran, T Liu, AH Kesarwala, X Yang	29/10/2021
A Call to Action: Radiation Oncology Trials and Minority Enrollment. Practical radiation oncology	AH Kesarwala, KD Godette, JD Bradley	01/01/2021
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer. Cell reports. Medicine	N Roper, AL Brown, JS Wei, S Pack, C Trindade, C Kim, O Restifo, S Gao, S Sindiri, F Mehrabadi, R El Meskini, ZW Ohler, TK Maity, A Venugopalan, CM Cultraro, E Akoth, E Padiernos, H Chen, A Kesarwala, DK Smart, N Nilubol, A Rajan, Z Piotrowska, L Xi, M Raffeld, AR Panchenko, C Sahinalp, S Hewitt, CD Hoang, J Khan, U Guha	21/04/2020
Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting. Advances in radiation oncology	G Suneja, MD Mattes, RB Mailhot Vega, FE Escorcia, C Lawton, J Greenberger, AH Kesarwala, A Spektor, B Vikram, C Deville, M Siker	01/01/2020

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.